ONCOCYTE CORP (OCX) Stock Analyst Earnings Estimates
NASDAQ:OCX - Nasdaq - US68235C2061 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.2M 80.33% | 960K -56.36% | 1.503M 56.56% | 505K -66.40% | 1.042M 106.34% | 5.757M 452.50% | |
| EBITDA YoY % growth | -47.07M -62.87% | 7.41M 115.74% | -14.826M -300.08% | -11.817M 20.30% | -24.341M -105.98% | -19.695M 19.09% | |
| EBIT YoY % growth | -51.27M -75.04% | 2.19M 104.27% | -16.506M -853.70% | -33.734M -104.37% | -23.81M 29.42% | -20.15M 15.37% | |
| Operating Margin | -2,330.45% | 228.13% | -1,098.20% | -6,680.00% | -2,285.00% | -350.00% | |
| EPS YoY % growth | -0.44 4.35% | -13.20 -2,900.00% | -3.60 72.73% | -2.88 20.01% | -1.69 41.33% | -1.37 19.05% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.43 79.64% | -0.43 62.37% | -0.44 -22.23% | -0.41 57.71% | -0.41 5.62% | -0.38 11.28% | -0.34 21.61% | -0.33 20.67% | -0.31 23.51% |
| Revenue Q2Q % growth | 101K -67.83% | 160.085K -9.04% | 170.69K 64.13% | 179.78K 56.33% | 346.43K 243.00% | 707K 341.64% | 909K 432.54% | 1.111M 517.98% | 1.414M 308.16% |
| EBITDA Q2Q % growth | -2.121M 85.44% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.122M 62.31% | -6.112M 32.82% | -5.941M -28.26% | -5.795M 57.12% | -5.696M 6.96% | -5.959M 2.50% | -5.151M 13.29% | -4.848M 16.35% | -4.545M 20.21% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.98 -20.99% | -0.44 | -0.54 | -122.55% |
| Q2 2024 Q2Q % growth | -0.36 66.36% | -0.56 | 0.20 | 36.24% |
| Q1 2024 Q2Q % growth | -1.13 -382.50% | -0.68 | -0.45 | -67.40% |
| Q4 2023 Q2Q % growth | -2.12 73.50% | -1.15 | -0.97 | -84.61% |
| Q3 2023 Q2Q % growth | -0.81 49.38% | -1.02 | 0.21 | 20.40% |
| Q2 2023 Q2Q % growth | -1.07 23.57% | -1.31 | 0.24 | 18.51% |
| Q1 2023 Q2Q % growth | 0.40 118.18% | -1.86 | 2.26 | 121.52% |
| Q4 2022 Q2Q % growth | -8.00 -6,566.67% | -1.90 | -6.10 | -320.42% |
| Q3 2022 Q2Q % growth | -1.60 -966.67% | -2.28 | 0.68 | 29.80% |
| Q2 2022 Q2Q % growth | -1.40 -1,066.67% | -2.41 | 1.01 | 41.92% |
| Q1 2022 Q2Q % growth | -2.20 -4,300.00% | -2.42 | 0.22 | 9.24% |
| Q4 2021 Q2Q % growth | -0.12 -33.33% | -0.13 | 0.01 | 6.55% |
| Q3 2021 Q2Q % growth | -0.15 -50.00% | -0.12 | -0.03 | -28.03% |
| Q2 2021 Q2Q % growth | -0.12 14.29% | -0.10 | -0.02 | -18.81% |
| Q1 2021 Q2Q % growth | -0.05 61.54% | -0.10 | 0.05 | 50.50% |
| Q4 2020 Q2Q % growth | -0.09 35.71% | -0.11 | 0.02 | 18.99% |
| Q3 2020 Q2Q % growth | -0.10 | -0.10 | 0.00 | -4.22% |
| Q2 2020 Q2Q % growth | -0.14 -40.00% | -0.11 | -0.03 | -33.28% |
| Q1 2020 Q2Q % growth | -0.13 -62.50% | -0.11 | -0.02 | -21.43% |
| Q4 2019 Q2Q % growth | -0.14 | -0.09 | -0.05 | -50.67% |
| Q3 2019 Q2Q % growth | -0.10 | -0.09 | -0.01 | -15.13% |
| Q2 2019 Q2Q % growth | -0.10 | -0.09 | -0.01 | -12.51% |
| Q1 2019 Q2Q % growth | -0.08 | -0.09 | 0.01 | 11.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 115K -73.19% | 202K | -87K | -43.07% |
| Q2 2024 Q2Q % growth | 104K -77.54% | 321.685K | -217.685K | -67.67% |
| Q1 2024 Q2Q % growth | 176K -40.74% | 353.5K | -177.5K | -50.21% |
| Q4 2023 Q2Q % growth | 314K 16.30% | 319.837K | -5.837K | -1.82% |
| Q3 2023 Q2Q % growth | 429K 512.86% | 315.625K | 113.375K | 35.92% |
| Q2 2023 Q2Q % growth | 463K 92.92% | 366.125K | 96.875K | 26.46% |
| Q1 2023 Q2Q % growth | 297K -21.84% | 349.864K | -52.864K | -15.11% |
| Q4 2022 Q2Q % growth | 270K 113.92% | 1.438M | -1.168M | -81.22% |
| Q3 2022 Q2Q % growth | 70K -92.86% | 1.5M | -1.43M | -95.33% |
| Q2 2022 Q2Q % growth | 240K -88.18% | 2.725M | -2.485M | -91.19% |
| Q1 2022 Q2Q % growth | 380K -66.07% | 2.26M | -1.88M | -83.19% |
| Q4 2021 Q2Q % growth | -1.94M -488.00% | 3.667M | -5.607M | -152.90% |
| Q3 2021 Q2Q % growth | 980K 75.00% | 1.778M | -798K | -44.88% |
| Q2 2021 Q2Q % growth | 2.03M 1,350.00% | 1.582M | 448K | 28.32% |
| Q1 2021 Q2Q % growth | 1.12M 5,500.00% | 841.663K | 278.337K | 33.07% |
| Q4 2020 Q2Q % growth | 500K | 831.563K | -331.563K | -39.87% |
| Q3 2020 Q2Q % growth | 560K | 374.882K | 185.118K | 49.38% |
| Q2 2020 Q2Q % growth | 140K | 47.672K | 92.328K | 193.67% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.78% | 5.18% | 0% | -24.8% |
| Revenue | 0% | -60% | 0% | -24.62% |